Management of Acute Asthma Exacerbation in a 44-Year-Old
Immediately administer albuterol 2.5-5 mg via nebulizer every 20 minutes for 3 doses (or 4-8 puffs via MDI every 20 minutes), add ipratropium bromide 0.5 mg every 20 minutes for 3 doses, and give oral corticosteroids 40-80 mg prednisone or equivalent as a single dose. 1
Initial Assessment and Immediate Treatment
Upon presentation, rapidly assess severity through:
- Oxygen saturation (maintain >90% with supplemental O2)
- Peak expiratory flow (PEF) if patient can perform
- Work of breathing, ability to speak in full sentences
- Heart rate, respiratory rate
Start treatment immediately—do not delay for complete assessment 2
First-Line Therapy (First Hour)
Bronchodilators
Albuterol nebulizer: 2.5-5 mg every 20 minutes for 3 doses, then reassess 1
- Alternative: MDI with spacer 4-8 puffs every 20 minutes (equally effective with proper technique)
- For continuous symptoms: 10-15 mg/hour by continuous nebulization 1
Add ipratropium bromide: 0.5 mg every 20 minutes for 3 doses 1
Corticosteroids
- Oral prednisone 40-80 mg in single or divided doses 1
Oxygen
- Maintain SpO2 ≥90% 2
Severe Exacerbation—Additional Therapies
If patient shows signs of severe exacerbation (inability to speak in sentences, accessory muscle use, PEF <40% predicted, poor response to initial bronchodilators):
Magnesium Sulfate
- IV magnesium sulfate infusion reduces hospitalizations 2
- Use early in severe cases—waiting diminishes benefit 3
Consider Heliox
Reassessment at 1 Hour
After initial 3 doses of bronchodilators:
Good response (speaking comfortably, PEF >70%, SpO2 >90%):
- Continue albuterol every 1-4 hours as needed
- Continue oral corticosteroids
- Consider discharge if sustained improvement
Incomplete response (PEF 40-69%, persistent symptoms):
- Continue frequent albuterol (every 1-4 hours)
- Add magnesium sulfate if not already given
- Observe for 4 hours minimum 4
Poor response (PEF <40%, drowsiness, confusion, silent chest):
- Prepare for possible intubation
- Transfer to ICU
- Continue aggressive bronchodilator therapy
- IV corticosteroids (though no proven advantage over oral) 1
Common Pitfalls to Avoid
- Do not use SABA alone without corticosteroids—all adults with asthma exacerbations need ICS-containing therapy 5
- Do not continue ipratropium after hospital admission—no proven benefit 1
- Do not delay corticosteroids—early administration is critical 3
- Do not use IV corticosteroids routinely—oral is equally effective and preferred 1
- Do not use systemic beta-agonists (epinephrine, terbutaline)—no advantage over inhaled route 1
Disposition Planning
Discharge criteria (after 4 hours observation):
- PEF 60-80% of predicted and sustained 2
- Minimal symptoms at rest
- Not requiring albuterol more frequently than every 4 hours
- Adequate home support and follow-up arranged 4
Discharge medications:
- Prednisone 40-60 mg daily for 5-10 days total 1
- Albuterol inhaler for rescue
- Initiate or step up ICS maintenance therapy 2
- Written asthma action plan 5
- Follow-up within 3-5 days 4
Admit if:
- PEF remains <60% predicted
- Continued frequent bronchodilator requirement
- High-risk features (prior intubation, recent hospitalization, poor access to care)